119. Manna, S. K., A. Mukhopadhyay, B. B. Aggarwal, “Resveratrol Suppresses TNF-Induced Activation of Nuclear Transcription Factors NF-[kappa]B, Activator Protein-1, and Apoptosis: Potential Role of Reactive Oxygen Intermediates and Lipid Peroxidation,” Journal of Immunology 164, no. 12 (2000): 6509-19.

   120. Kaeberlein, M., T. McDonagh, B. Heltweg, et al., “Substrate-Specific Activation of Sirtuins by Resveratrol,” Journal of Biological Chemistry 280, no. 17 (2005): 17038-45.

   121. Lappe, J. M., K. Travers-Gustafson, K. M. Davies, “Vitamin D and Calcium Supplementation Reduces Cancer Risk: Results of a Randomized Trial,” American Journal of Clinical Nutrition 85 (2007): 1586-91.

   122. Woo, T. C. S., et al., “Pilot Study: Potential Role of Vitamin D (Cholecalciferol) in Patients with PSA Relapse After Definitive Therapy,” Nutrition & Cancer 51, no. 1 (2005): 32-36.

   123. Cannell, J. J. and B. W. Hollis, “Use of Vitamin D in Clinical Practice,” Alternative Medicine Review 13 (2003).

   124. Canadian Cancer Society, “La Société Canadienne du Cancer Annonce Ses Recommandations Concernant la Vitamine D,” 2007. (Accessed June 10, 2007, at www.cancer.ca.)

   125. Chan, Holick, Leitzman, et al., “Diet After Diagnosis and the Risk of Prostate Cancer Progression, Recurrence, and Death.”

   126. Gago-Dominguez, M., J. Yuan, C. Sun, et al., “Opposing Effects of Dietary n-3 and n-6 Fatty Acids on Mammary Carcinogenesis: The Singapore Chinese Health Study,” British Journal of Cancer 89, no. 9 (2003): 1686-92.

   127. Goodstine, S. L., T. Zheng, T. R. Holford, et al., “Dietary (n-3)/(n-6) Fatty Acid Ratio: Possible Relationship to Premenopausal but Not Postmenopausal Breast Cancer Risk in U.S. Women,” Journal of Nutrition 133, no. 5 (2003): 1409-14.

   128. Leitzmann, M., M. Stampfer, D. Michaud, et al., “Dietary Intake of n-3 and n-6 Fatty Acids and the Risk of Prostate Cancer,” American Journal of Clinical Nutrition 80 (2004): 204-16.

   129. Hedelin, M., “Association of Frequent Consumption of Fatty Fish with Prostate Cancer Risk Is Modified by COX-2 Polymorphism,” Internation Journal of Cancer 120, no. 2 (2006): 398-405.

   130. Norat, T., S. Bingham, P. Ferrari, et al., “Meat, Fish, and Colorectal Cancer Risk: The European Prospective Investigation into Cancer and Nutrition,” Journal of the National Cancer Institute 97, no. 12 (2005): 906-16.

   131. Terry, P., A. Wolk, H. Vainio, et al., “Fatty Fish Consumption Lowers the Risk of Endometrial Cancer: A Nationwide Case-Control Study in Sweden,” Cancer Epidemiology, Biomarkers & Prevention 11, no. 1 (2002): 143-45.

   132. Terry, P., P. Lichtenstein, M. Feychting, et al., “Fatty Fish Consumption and Risk of Prostate Cancer,” Lancet 357, no. 9270 (2001): 1764-66.

   133. Hooper, L. T., R. Thompson, R. Harrison, et al., “Risks and Benefits of Omega 3 Fats for Mortality, Cardiovascular Disease, and Cancer: Systematic Review,” British Medical Journal 332 (2006): 752-60.

   134. MacLean, C. H., S. J. Newberry, W. A. Mojica, et al., “Effects of Omega-3 Fatty Acids on Cancer Risk: A Systematic Review,” JAMA 295, no. 4 (2006): 403-15.

   135. Norat, Bingham, Ferrari, et al., “Meat, Fish, and Colorectal Cancer Risk.”

   136. George, S. L., et al., “Impact of Flaxseed Supplementation and Dietary Fat Restriction on Prostate Cancer Proliferation and Other Biomarkers: Results of a Phase II Randomized Controlled Trial (RCT) Using a Presurgical Model,” Journal of Clinical Oncology 63S (2007).

   137. Bougnoux, P., et al., “Alpha-Linolenic Acid Content of Adipose Breast Tissue: A Host Determinant of the Risk of Early Metastasis in Breast Cancer,” British Journal of Cancer 70, no. 2 (1994): 330-34.

   138. Wollowski, I., G. Rechkemmer, and B. L. Pool-Zobel, “Protective Role of Probiotics and Prebiotics in Colon Cancer,” American Journal of Clinical Nutrition 73, no. 2 (2001): 451S-55.

   139. Kim, H. S., et al., “Dietary Supplementation of Probiotic Bacillus Polyfermenti cus, Bispan Strain, Modulates Natural Killer Cell and T Cell Subset Populations and Immunoglobulin G Levels in Human Subjects,” Journal of Medicinal Food 9, no. 3 (2006): 321-27.

   140. Rayman, M. P., “The Importance of Selenium to Human Health,” Lancet 356, no. 9225 (2000): 233-41.

   141. Kiremidjian-Schumacher, L., M. Roy, H. I. Wishe, “Supplementation with Selenium and Human Immune Cell Functions: II. Effect on Cytotoxic Lymphocytes and Natural Killer Cells,” Biological Trace Element Research 41, no. 1-2 (1994): 115-27.

<p id="__RefHeading___Toc443572764"><emphasis><strong>Глава 9</strong></emphasis></p>
Перейти на страницу:

Похожие книги